Global Aptamers Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts

DUBLIN, Dec. 2, 2021 /PRNewswire/ -- The "Aptamers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global aptamers market reached a value of US$ 4.3 Billion in 2020. Looking forward, the publisher expects the market to grow at a CAGR of around 20% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Aptamers are versatile oligonucleotides that bind to a specific target, including proteins, peptides, carbohydrates, small molecules, toxins, and live cells. They are modifiable, nonimmunogenic, highly sensitive, less toxic, easy to prepare and have low molecular weight and no variation with different preparations as compared to antibodies. As a result, they are widely being used in therapeutic and biotechnological applications. Besides this, they are also utilized as research agents, diagnostics, biosensors, and tools for biomarker or drug discovery worldwide.

Global Aptamers Market Trends:

The growing prevalence of life-threatening diseases, such as cancer, neurodegenerative, cardiovascular, and acquired immunodeficiency syndrome (AIDS), represents one of the key factors influencing the demand for new and effective detection assays based on aptamer therapy. Moreover, the advent of the chemical modification process to increase the nuclease resistance and enhance the therapeutic properties of aptamers is bolstering the market growth. The aptamers market growth can also be accredited to the rising number of research and development (R&D) activities undertaken for improving diagnostic devices and drugs and their carriers.

Apart from this, as aptamers are chemically synthesized, which eliminates batch-to-batch variation and requires less time for development, their application is extensively increasing across the globe. Furthermore, private organizations are collaborating with academic institutes and research laboratories to introduce next-generation products and expand their existing market presence. This is anticipated to fuel the usage of aptamers in a wide range of medical therapies, as well as in the food and beverage (F&B) industry.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aptagen LLC, Aptamer Group, Aptamer Sciences Inc., Aptus Biotech S.L., Base Pair Biotechnologies Inc., IBA GmbH, Kaneka Eurogentec S.A. (Kaneka Corporation), NeoVentures Biotechnology Inc., NOXXON Pharma, SomaLogic Inc., TriLink BioTechnologies LLC and Vivonics Inc.

Key Questions Answered in This Report:

• How has the global aptamers market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global aptamers market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global aptamers market and who are the key players?
• What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Aptamers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type
6.1 Nucleic Acid
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Peptide
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Application
7.1 Diagnostics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Therapeutics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Research and Developments
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast

8 Market Breakup by Region

9 SWOT Analysis

10 Value Chain Analysis

11 Porters Five Forces Analysis

12 Price Analysis

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Aptagen LLC
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.2 Aptamer Group
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Aptamer Sciences Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Aptus Biotech S.L.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 Base Pair Biotechnologies Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 IBA GmbH
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Kaneka Eurogentec S.A. (Kaneka Corporation)
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 NeoVentures Biotechnology Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 NOXXON Pharma
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.10 SomaLogic Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.11 TriLink BioTechnologies LLC
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.12 Vivonics Inc.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio

For more information about this report visit https://www.researchandmarkets.com/r/aqigl

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets